« Back
Home /
Terazosin HCl

Terazosin HCl

Item no.	M6000-50mg
Manufacturer	AbMole
CASRN	63074-08-8
Amount	50mg
Category	Oncology Metabolism Diabetes Glucose Homeostasis Inhibitors & Compound Libraries Small Molecules By Organ Heart & Blood Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Terazosin, Hytrin, Zayasel, Terazosine, Flumarc, Fosfomic, Blavin
Available
Target Information	Adrenergic Receptor
Molecular Weight	423, 89
Solubility	84 mg/mL in DMSO
Bioactivity information	Terazosin is a selective alpha-1 antagonist used for treatment of symptoms of an enlarged prostate (BPH). It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M6000-50mg-safety-datasheet.pdf